The development of biocompatible titanium and its alloys in China can be divided into three stages: the first stage was represented by pure titanium and TC4 titanium alloy, the second stage was represented by TC20 titanium alloy, a new type of α+β alloy, and the third stage was focused on developing and researching titanium alloys with better biocompatibility and lower elastic modulus, among which the research on β-type titanium alloys was the most extensive.
Industrial pure titanium was first applied in this field. Currently, the clinical experience of using pure titanium implants is relatively mature, but pure titanium cannot provide the comprehensive mechanical properties required for medical load-bearing materials, such as its low strength and poor wear resistance, which limit its application. TC20 titanium alloy has high wear resistance, high hardness, good surface properties, and excellent microstructure, with better performance than pure titanium. However, due to the presence of neurotoxic element Al in Ti-Al-Nb alloys, although its elastic modulus was the closest to human bone at that time, it was still 4-10 times that of human bone. If the elastic modulus between the implant and the bone does not match, the load cannot be well transferred from the implant to the adjacent bone tissue, resulting in a "stress shielding" phenomenon, which leads to bone resorption around the implant, eventually causing implant loosening or fracture, and resulting in implant failure. Therefore, the research and development of new medical titanium alloys with better biocompatibility and lower elastic modulus to meet the clinical demand for implant materials has become one of the main research contents of biomedical metallic materials. The biocompatibility of the β-type Ti-13Nb-13Zr alloy composed of non-toxic elements was studied, and the results showed that compared with TC4 alloy, the biocompatibility of Ti-13Nb-13Zr alloy was improved, that is, the alloy composed of non-toxic elements had better biocompatibility. In the future, the development of biocompatible titanium alloys with non-toxic composition elements and excellent mechanical properties can be expected to drive the development of titanium alloys for environmentally friendly structures. It is precisely these issues that determine the direction and trend of further research on biomedical titanium alloys.

